Angiopoietin-2 is associated with metabolic syndrome in chronic kidney disease
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
120
Journal Issue
12
Date Issued
2021-05-23
Author(s)
Ming-Ching Lee
Liu, Jia-Sin
Abstract
Metabolic syndrome is a subclinical status in promoting atherosclerotic cardiovascular disease and type 2 diabetes mellitus. The significance of metabolic syndrome and pathophysiology in chronic kidney disease is not investigated.
Subjects
Angiopoietin-2; Chronic kidney disease; Endothelial dysfunction; Inflammation; Metabolic syndrome
SDGs
Other Subjects
angiopoietin 1; angiopoietin 2; angiopoietin receptor; C reactive protein; diuretic agent; pentoxifylline; uric acid; vasculotropin A; angiopoietin 2; adult; aged; Article; chronic kidney failure; clinical feature; cohort analysis; controlled study; cross-sectional study; demography; disease association; estimated glomerular filtration rate; female; human; major clinical study; male; metabolic syndrome X; pathophysiology; prevalence; protein blood level; uric acid blood level; complication; glomerulus filtration rate; metabolic syndrome X; non insulin dependent diabetes mellitus; prospective study; Angiopoietin-2; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Metabolic Syndrome; Prospective Studies; Renal Insufficiency, Chronic
Type
journal article